Selective inhibitors of monoamine oxidase .3. Structure-activity relationship of tricyclics bearing imidazoline, oxadiazole, or tetrazole groups

被引:96
|
作者
Harfenist, M
Heuser, DJ
Joyner, CT
Batchelor, JF
White, HL
机构
[1] WELLCOME RES LABS,DIV PHARMACOL,RES TRIANGLE PK,NC 27709
[2] WELLCOME RES LABS,ANALYT DEV LABS,RES TRIANGLE PK,NC 27709
关键词
D O I
10.1021/jm950595m
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Inhibition of monoamine oxidase A (MAO A) is believed to cause antidepressant and possibly antianxiety effects. The previous paper had developed structure-activity relationships (SAR) for in vitro MAO A inhibition by tricyclic N-arylamides.(1) It is shown in this paper that the same in vitro SAR can be carried over to tricyclics whose potentially toxic amide function is replaced by an appropriately substituted imidazoline, a 1,2,4- or 1,3,4-oxadiazole, or an alkylated tetrazole moiety. Dialysis of the inhibitor from the enzyme was used as a measure of reversibility which correlates with a low ability to cause a blood pressure rise with ingested tyramine (''cheese effect'').
引用
收藏
页码:1857 / 1863
页数:7
相关论文
共 50 条
  • [1] Structure-Activity Relationship Analysis of 3-Phenylcoumarin-Based Monoamine Oxidase B Inhibitors
    Rauhamaki, Sanna
    Postila, Pekka A.
    Niinivehmas, Sanna
    Kortet, Sami
    Schildt, Emmi
    Pasanen, Mira
    Manivannan, Elangovan
    Ahinko, Mira
    Koskimies, Pasi
    Nyberg, Niina
    Huuskonen, Pasi
    Multamaki, Elina
    Pasanen, Markku
    Juvonen, Risto O.
    Raunio, Hannu
    Huuskonen, Juhani
    Pentikainen, Olli T.
    FRONTIERS IN CHEMISTRY, 2018, 6
  • [2] STRUCTURE-ACTIVITY RELATIONSHIPS OF MONOAMINE-OXIDASE INHIBITORS
    FUJITA, T
    JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (08) : 923 - 930
  • [3] Quantitative Structure-Activity Relationship and Complex Network Approach to Monoamine Oxidase A and B Inhibitors
    Santana, Lourdes
    Gonzalez-Diaz, Humberto
    Quezada, Elias
    Uriarte, Eugenio
    Yanez, Matilde
    Vina, Dolores
    Orallo, Francisco
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (21) : 6740 - 6751
  • [4] QUANTITATIVE STRUCTURE-ACTIVITY STUDIES ON MONOAMINE-OXIDASE INHIBITORS
    JOHNSON, CL
    JOURNAL OF MEDICINAL CHEMISTRY, 1976, 19 (05) : 600 - 605
  • [5] STRUCTURE AND ACTIVITY RELATIONSHIP OF MONOAMINE OXIDASE INHIBITORS, PHENYLACETYLHYDRAZIDE DERIVATIVES
    NAKAMURA, K
    MASUDA, Y
    TATSUMI, H
    FUJIMOTO, K
    JAPANESE JOURNAL OF PHARMACOLOGY, 1963, 13 (02): : 186 - &
  • [6] Structure-Activity Relationship of Xanthones as Inhibitors of Xanthine Oxidase
    Zhou, Ling-Yun
    Peng, Jia-Le
    Wang, Jun-Ming
    Geng, Yuan-Yuan
    Zuo, Zhi-Li
    Hua, Yan
    MOLECULES, 2018, 23 (02):
  • [7] Docking and quantitative structure-activity relationship of oxadiazole derivates as inhibitors of GSK3
    Quesada-Romero, Luisa
    Caballero, Julio
    MOLECULAR DIVERSITY, 2014, 18 (01) : 149 - 159
  • [8] Deciphering the detailed structure-activity relationship of coumarins as Monoamine oxidase enzyme inhibitors-An updated review
    Koyiparambath, Vishal Payyalot
    Prayaga Rajappan, Krishnendu
    Rangarajan, T. M.
    Al-Sehemi, Abdullah G.
    Pannipara, Mehboobali
    Bhaskar, Vaishnav
    Nair, Aathira Sujathan
    Sudevan, Sachithra Thazhathuveedu
    Kumar, Sunil
    Mathew, Bijo
    CHEMICAL BIOLOGY & DRUG DESIGN, 2021, 98 (04) : 655 - 673
  • [9] ISOLATION OF MONOAMINE-OXIDASE INHIBITORS FROM GLYCYRRHIZA-URALENSIS ROOTS AND THE STRUCTURE-ACTIVITY RELATIONSHIP
    TANAKA, S
    KUWAI, Y
    TABATA, M
    PLANTA MEDICA, 1987, (01) : 5 - 8
  • [10] Computational investigation on the structure-activity relationship of the biradical mechanism for monoamine oxidase
    Erdem, Safiye S.
    Buyukmenekse, Burcu
    JOURNAL OF NEURAL TRANSMISSION, 2011, 118 (07) : 1021 - 1029